Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and Amyloid precursor protein (AβPP) expression in rat brain

Indian Journal of Pharmacology

Volumn 44, Issue 5, 2012, Pages 593-598

  Bihaqi, Syed ^a,c   Singh, Avninder ^b   Tiwari, Manisha ^c  

^a UNIVERSITY OF RHODE ISLAND   (United States)

^b SAFDARJUNG HOSPITAL CAMPUS   (India)

^c UNIVERSITY OF DELHI   (India)

Author keywords

Alzheimer s disease; amyloid beta; amyloid precursor protein; scopolamine; tau

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CONVOLVULUS PLURICAULIS EXTRACT; MESSENGER RNA; NEUROPROTECTIVE AGENT; PLANT EXTRACT; RIVASTIGMINE; SCOPOLAMINE; TAU PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; CONVOLVULUS; CONVOLVULUS PLURICAULIS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HISTOPATHOLOGY; MALE; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALZHEIMER'S DISEASE; AMYLOID BETA; AMYLOID PRECURSOR PROTEIN; SCOPOLAMINE; TAU;

AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CEREBRAL CORTEX; CONVOLVULUS; GENE EXPRESSION REGULATION; MALE; PLANT EXTRACTS; PLANT ROOTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; SCOPOLAMINE HYDROBROMIDE; TAU PROTEINS;

EID: 84866240546     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.100383     Document Type: Article

References (30)

1. Selkoe DJ. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 2000;924:17-25.
2. Koudinov AR, Koudinova NV. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci 2005;229-230:233-40.
3. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: Relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 2002;68:209-45.
4. Balschun D, Wolfer DP, Gass P, Mantamadiotis T, Welzl H, Schutz G, et al. Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory. J Neurosci 2003;23:6304-14.
5. Maccioni RB, Munoz JP, Barbeito L. The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 2001;32:367-81.
6. Chauhan NB. Effect of aged garlic extract on APP processing and tau phosphorylation in Alzheimer's transgenic model Tg2576. J Ethnopharmacol 2006;108:385-94.
7. Weinstock M. The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: An update. Neurodegeneration 1995;4:349-56.
8. Deshpande SM, Srivastava DN. Chemical studies of Convolvulus pluricaulis. J Indian Chem Soc 1969;46:759-60.
9. Deshpande SM, Srivastava DN. Chemical examination of the fatty acids of Convolvulus pluricaulis. Indian Oil Soap J 1969;34:217-8.
10. Bardgett ME, Henry JD. Locomotor activity and accumbens fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors. Neuroscience 1999;94:59-70.
11. Nahata A, Patil UK, Dixit VK. Effect of Convulvulus pluricaulis choisy. on learning behaviour and memory enhancement activity in rodents. Nat Prod Res 2008;22:1472-82.
12. Bihaqi SW, Singh AP, Tiwari M. In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian J Pharmacol 2011;43:520-5.
13. Sreevidya N, Mehrotra S. Spectrophotometric method for estimation of alkaloids precipitable with Dragendorff's reagent in plant materials. J AOAC Int 2003;86:1124-7.
14. Dignam JD, Martin PL, Shastry BS, Roeder RG. Eukaryotic gene transcription with purifi ed components. Methods Enzymol 1983;101:582-98.
15. Morishima-Kawashima M, Oshima N, Ogata H, Yamaguchi H, Yoshimura M, Sugihara S, et al. Effect of apolipoprotein E allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am J Pathol 2000;157:2093-9.
16. Nakayama H, Ginsberg MD, Dietrich WD. (S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat. Neurology 1988;38:1667-73.
17. Mirzaev YR, Aripova SF. Neuro and psychopharmacological investigation of the alkaloids convolvine and atropine. Chem Nat Compounds 1998;34:56-8.
18. Ross JA, Kasum CM. Dietary fl avonoids: Bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19-34.
19. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, et al. Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting infl ammatory activation of microglia. FASEB J 2003;17:1943-4.
20. Dunnett SB. Comparative effects of cholinergic drugs and lesions of nucleus basalis or fi mbria-fornix on delayed matching in rats. Psychopharmacology (Berl) 1985;87:357-63.
21. Moran MA, Mufson EJ, Gomez-Ramos P. Colocalization of cholinesterases with β-amyloid protein in aged and Alzheimer's brain. Acta Neuropathol 1993;85:362-9.
22. Lahiri DK, Farlow MR, Nurnberger JJ, Greig NH. Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures. Ann N Y Acad Sci 1997;826:416-21.
23. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, et al. Acetylcholinesterase accelerates assembly of amyloid-β peptides into Alzheimer's fi brils: Possible role of the peripheral site of the enzyme. Neuron 1996;16:881-91.
24. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 1999;402:615-22.
25. Schliebs R, Arendt T, The cholinergic system in aging and neuronal degeneration. Behav Brain Res 2011;221:555-63.
26. Park SY, Ferreira A. The generation of a 17 kDa neurotoxic fragment: An alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 2005;25:5365-75.
27. Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci U S A 2006;103:2892-7.
28. Reifert J, Hartung-Cranston D, Feinstein SC. Amyloid β-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation. J Biol Chem 2011;286:20797-811.
29. Hsieh MT, Hsieh CL, Lin LW, Wu CR, Huang GS. Differential gene expression of scopolamine-treated rat hippocampus-application of cDNA microarray technology. Life Sci 2003;73:1007-16.
30. Bihaqi SW, Sharma M, Singh AP, Tiwari M. Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol 2009;124:409-15.